Comparison

Vibostolimab European Partner

Item no. HY-P99202-1mg
Manufacturer MedChem Express
CASRN 2231305-30-7
Amount 1 mg
Category
Type Inhibitor
Specific against other
Purity 96.54
Dry ice Yes
Citations [1]Niu J, et al. First-in-human phase 1 study of the anti-TIGIT antibody vibostolimab as monotherapy or with pembrolizumab for advanced solid tumors, including non-small-cell lung cancer☆. Ann Oncol. 2022 Feb;33(2):169-180.
Smiles [Vibostolimab]
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Available
Product Description
Vibostolimab is an anti-TIGIT (T cell immunoglobulin and ITIM domain) monoclonal antibody. Vibostolimab shows antitumor activity, and can be used in non-small cell lung cancer (NSCLC) and melanoma research[1].
StorageTemperature
Store at -80°C for 2 years
Shipping
Dry Ice
Manufacturers Applications
Cancer-programmed cell death
MolecularWeight
N/A
Clinical_Information
Phase 2
Manufacturers Research_Area
Cancer
Solubility
10 mM in DMSO
Manufacturers Target
Others
Pathway
Others
Manufacturers Product type
Inhibitory Antibodies

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close